Erasca (ERAS) Times Interest Earned (2020 - 2026)

Erasca (ERAS) posted Times Interest Earned of -$0.28 for Q1 2026, up 98.72% on a QoQ basis from -$21.74 in Q4 2025, and up 98.82% year-over-year from -$0.14 in Q1 2025.

Erasca (ERAS) Times Interest Earned (2020 - 2026) Analysis & Trends

Erasca's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.28 for Q1 2026.

  • Quarterly Times Interest Earned rose 98.82% year-over-year to -$0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.44 (up 98.42% YoY) and the FY2025 annual result came in at -$0.58, up 95.79% from the prior year.
  • Times Interest Earned was -$0.28 for Q1 2026 at Erasca, up from -$21.74 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.28 in Q1 2026 and bottomed at -$139.05 in Q4 2022.
  • A 5-year average of -$14.23 and a median of -$2.16 in 2025 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2022 — Times Interest Earned jumped 99.26% — and 2023, when it tumbled 678.69%.
  • Erasca's Times Interest Earned stood at -$139.05 in 2022, then jumped by 88.93% to -$15.4 in 2023, then tumbled by 36.44% to -$21.01 in 2024, then dropped by 3.47% to -$21.74 in 2025, then jumped by 98.72% to -$0.28 in 2026.
  • Business Quant data shows ERAS's Times Interest Earned at -$0.28 in Q1 2026, -$21.74 in Q4 2025, and -$2.09 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Erasca 5.89 Bn 5.89 Bn - -0.28

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.28
Dec 31, 2025 -21.74
Sep 30, 2025 -2.09
Jun 30, 2025 -2.16
Mar 31, 2025 -23.75
Dec 31, 2024 -21.01
Sep 30, 2024 -2.24
Jun 30, 2024 -0.89
Mar 31, 2024 -5.16
Dec 31, 2023 -15.40
Sep 30, 2023 -1.34
Jun 30, 2023 -0.42
Mar 31, 2023 -4.23
Dec 31, 2022 -139.05
Sep 30, 2022 -0.42
Jun 30, 2022 -1.17
Mar 31, 2022 -0.54
Dec 31, 2021 -104.54
Sep 30, 2021 -0.19
Jun 30, 2021 -0.34